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Abstract 
Purpose: Caffeine ingestion is widely accepted for its ergogenic properties. Recent 
evidence suggests that mouth rinsing with caffeine prior to exercise can improve short 
duration sprint performance. The purpose of this study was to examine whether the 
benefits of caffeine mouth rinsing can be extended to include sustained high intensity 
performance and whether a caffeine rinse can provide additive value to the performance 
benefits of caffeine intake (i.e. caffeine ingestion plus caffeine rinse > caffeine 
ingestion). Methods: 25 recreational cyclists performed six separate 3-km time trials (2 
familiarization and 4 treatment trials), each trial separated by 3-7 days. Subjects were 
given a combination of caffeine and placebo capsules (6mg/kg body weight taken one 
hour prior to trial) and mouth-rinses (1.2% weight/volume administered immediately 
prior). Thus, the treatments were: PLA-PLA, PLA-CAF, CAF-CAF, CAF-PLA (capsule- 
mouth-rinse). Treatments were provided in a randomized, counterbalanced, double 
blind, placebo controlled fashion. Magnitude-based qualitative inferences were applied 
to evaluate treatment differences. Results: Caffeine ingestion led to better cycling 
performance, as CAF-CAF and CAF-PLA treatments both ‘likely’ improved performance 
time by 1.4% and 1.7% compared to PLA-PLA, while also improving average power 
output. The effects of the caffeine mouth-rinse on 3-km time trial performance were 
unclear compared to placebo conditions. Conclusion: Caffeine ingestion enhanced 
short, high intensity cycling time trial performance, while the caffeine mouth-rinse had 
unclear effects. Collectively, these data confirm that caffeine ingestion is useful as an 
ergogenic aid for high intensity cycling, while a caffeine mouth-rinse does not appear to 
have similar ergogenic effects.  
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Chapter 1 
Introduction 
 Caffeine is widely recognized as a performance-enhancing agent.  Initial 
evidence for the performance benefit of caffeine intake was demonstrated by Costill 
(1977) who reported that 330 mg of caffeine extended cycling time to exhaustion (80% 
VO2max) by approximately 20%.  Subsequent research has confirmed this finding 
(Pasman, 1995, Cole, 1996; Greer, 2000; Jenkins, 2008; and McNaughton, 2008). More 
recent work has indicated that caffeine can also improve power output during anaerobic 
exercise (Bell et al., 2001), as well as repeated sprint performance (Beaven et al., 
2012). Many of these studies also indicated that caffeine intake elevated blood lactate 
and heart rate, either as a direct effect of the caffeine or as a function of being able to 
perform at higher intensities (Anselme et al., 1992). However, it is unlikely that caffeine 
raises blood lactate because of increased anaerobic glycolysis, as a number of studies 
have shown increased blood lactate without increased muscle lactate (Erickson, 1987 
and Bell, 2002). It is worth noting that the performance benefits of caffeine have not 
been consistently reported (Bell, 1998, Doherty, 2002, and Beck, 2008). Though it is 
clear that not all individuals favorably respond to caffeine under all conditions, on 
balance caffeine appears to deliver considerable performance benefits.  
 Though the physiological mechanisms responsible for the ergogenic effect of 
caffeine are not completely understood, one plausible explanation involves CNS 
stimulation. Following liver metabolism, caffeine can readily cross the blood-brain 
barrier due to its lipophilic nature (Davis, 2003 and McCall, 1982), whereby it 
antagonizes adenosine, an inhibitory neurotransmitter. Thus, caffeine has been shown 
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to counteract many of the inhibitory effects of adenosine, consequently enhancing 
neuroexcitability, neurotransmitter release, and arousal (Davis, 2003). Likely through 
this mechanism, pre-exercise caffeine intake can decrease perception of effort and by 
extension can lead to greater workloads when riding at a fixed perceived exertion (RPE) 
(Cole, 1996). A separate and less likely mechanism for caffeine-induced performance 
gains is the idea that caffeine can create a more favorable intracellular environment in 
working skeletal muscles (Graham, 2001). This is theoretically accomplished by 
maintaining electrolyte homeostasis, which perhaps would increase force production per 
motor unit and/or increase motor unit recruitment during exercise. However, this theory 
has been called into question (Davis, 2003 and Jenkins, 2008).  
 Like many drugs that target the central nervous system (i.e. ephedrine, 
amphetamine, and nicotine), caffeine ingestion can elicit a number of negative side 
effects. Large doses of caffeine can increase the risk of hypovolemia given the 
purported diuretic effects of caffeine (Bytomski and Parker, 2011).  Large doses of 
caffeine can also lead to symptoms such as nervousness, irritability, muscle twitching, 
heart palpitations, and respiratory alkalosis (Bytomski and Parker, 2011). It should also 
be noted that regularly using caffeine intake prior to exercise can induce a tolerance 
adaptation; meaning higher doses are required to elicit the same ergogenic effect 
(Bytomski and Parker, 2011), perhaps amplifying certain side effects.   
 Interestingly, there is recent evidence that caffeine can benefit performance 
without using traditional means of ingestion.  For example, chewing caffeinated gum 
immediately prior to exercise improved repeated sprint performance (Paton et al., 
2010). A similar study reported that a caffeine solution rinsed in the mouth immediately 
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prior to exercise (without ingestion) elicited a rapid increase in maximal voluntary power 
production (Beaven et al., 2012). Although the mechanism through which sprint 
performance was improved is unclear, it may be similar to what has been demonstrated 
with the mouth rinsing of carbohydrate. For example, Carter (2004) found that a 
carbohydrate mouth-rinse had a positive effect on 1-hour time trial cycling performance, 
while Rollo (2008) observed an increase in total distance covered during a 30-minute 
run when rinsing with a carbohydrate rinse vs. a placebo rinse. Together these data 
support the presence of oropharyngeal caffeine receptors that may be providing 
feedback to the brain, thereby eliciting an excitatory effect. One of the possible benefits 
of a caffeine mouth-rinse treatment as opposed to caffeine ingestion is that the rinse 
should minimize many of the negative systemic side effects of caffeine, since the rinse 
would be affecting the body neurally, not systemically.  Similarly, because some authors 
have reported that caffeine has no effect on high intensity cycling performance (Bell, 
1998, Jacobson et al., 2001, and Doherty, 2002), a caffeine mouth-rinse may be able to 
elicit ergogenic benefits to individuals who fail to respond to caffeine ingestion.  
While the findings of Paton and Beaven highlighted above provide initial support 
for the possible benefits of a caffeine mouth-rinse (Paton, 2010 and Beaven, 2012), it is 
unknown whether a caffeine mouth-rinse influences sustained high intensity 
performance. Similarly, the possibility that caffeine ingestion and mouth rinse could 
enhance performance more than either one alone has not yet been examined. As a 
result, the purpose of this investigation was to determine whether or not rinsing with 
caffeine enhances 3-km cycling performance, while also investigating the potentially 
added benefit of both ingesting and rinsing with caffeine prior to high intensity cycling.  
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Chapter 2 
Methodology 
Subjects:  
 Twenty-five recreationally active college-aged males and females were recruited 
from James Madison University and the surrounding Harrisonburg area. Subject 
characteristics are described in Table 1. Subjects were free of medications and at 
minimum performed intermittent cycling over the past two months. Subjects were 
provided with written and verbal information about the experimental procedures and 
potential risks prior to completing the informed consent.  The James Madison University 
Institutional Review Board approved all procedures.  
 
Experimental Overview: 
Familiarization and Treatment Trials 
 Subjects performed six separate 3-km cycling time trials on a computerized 
Racermate Veletron bicycle ergometer (Seattle, WA).  Each trial was separated by 3-7 
days and all were completed at the same time of day (2 hours). The two initial trials 
were familiarization trials to minimize any training or learning effect that would occur 
during the subsequent experimental trials. The remaining four visits included four 
experimental trials where separate treatments were provided in a randomized, 
counterbalanced, double blind, placebo controlled fashion. Subjects were encouraged 
to treat each trial as a competition. Subjects did not receive any verbal feedback or 
encouragement during the trials, and only elapsed distance was displayed on the 
computer monitor. The primary dependant measures were time to complete the 3-km 
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time trial and average power output. Further, time and average power output were 
calculated for each 1-km increment to assess any influence that caffeine may have had 
on pacing strategy.  
 
Treatments 
 No treatments were provided during the familiarization trials, with the exception 
of a pre-exercise practice mouth rinse (water). The experimental trials included the 
following treatments: 1. Caffeine mouth rinse (PLA-CAF); mouth rinse solution 
administered immediately prior to- and during exercise where subjects were instructed 
to only rinse the caffeine solution in their mouths and then spit it out (without 
swallowing). A placebo pill was also administered 1 hour prior to exercise. 2.  Caffeine 
pill (CAF-PLA); subjects ingested a caffeine pill (6mg/kg body weight) whole (to avoid 
any contact with oral receptors) 1 hour prior to exercise. A placebo mouth rinse solution 
was also administered. 3. Caffeine pill + caffeine mouth rinse (CAF-CAF); a caffeine pill 
and caffeine mouth rinse were administered. 4. Placebo (PLA-PLA); a placebo pill and 
placebo mouth rinse were administered. When reporting different treatment types, ‘PLA’ 
and ‘CAF’ are used for simplicities sake. The first letters represent the capsule 
treatment, while the second represent the mouth-rinse treatment. Thus, PLA-CAF would 
represent the PLA capsule and CAF mouth-rinse, and so on.  
 All mouth rinses (25 ml) were administered in Dixie cups and were comprised of 
saccharine (Sweet N’ Low) and water with or without caffeine (1.2% weight/volume). 
Rinses were provided 5 minutes prior to the time trial and again 30 seconds prior to the 
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time trial. The solution was swished around in the mouth for 5 seconds, upon which it 
was expectorated. 
Dietary, Exercise, and Time of Day Controls: 
 Subjects recorded food intake 24 hours prior to their first experimental trial. The 
subjects were then provided with a copy of their initial dietary log, which they were 
instructed to replicate for the 24 hrs preceding each subsequent experimental trial. 
Additionally, subjects abstained from any alcohol and caffeine for 24 hours and 12 
hours prior to the experimental trials, respectively. Finally, subjects avoided food intake 
for 2 hours preceding each experimental trial.  
 Subjects also refrained from heavy/unaccustomed exercise for 48 hrs prior to 
each experimental trial, recorded all physical activity performed during this time frame, 
and maintain consistent exercise habits between trials. All experimental trials were 
separated by 3-7 days and performed at the same time of day (within a 2-hour range).  
 
Statistics: 
Univariate Analysis of Variance (ANOVA) was applied to determine treatment 
differences for all variables. Simple contrasts between treatment conditions were used 
to generate P values for subsequent analysis as described below. Statistical analyses 
were performed using IBM Statistical Package for Social Sciences (SPSS) 21 for 
Macintosh (SPSS Inc., Chicago, IL, USA).   
Magnitude-based inferences about the data were derived using methods 
described by Hopkins and colleagues (Hopkins et al., 2009). A previously established 
‘smallest worthwhile change’ in performance was used as the threshold value for a 
 13 
substantial treatment effect (separate treatment conditions vs. placebo) (Hopkins, 
2004). The smallest worthwhile change in performance has been defined as 0.3 x the 
within subject variability across repeated time trials (Hopkins, 2004). The coefficients of 
variability for the performance parameters were derived from the familiarization trials of 
the current investigation. 
A published spreadsheet (Hopkins, 2007) was then used to determine the 
likelihoods of the true treatment effect (of the population) reaching the substantial 
change threshold (0.3 x CV); these were classified as <1% almost certainly no chance, 
1-5% = very unlikely, 5-25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = 
very likely, and >99% = almost certain. If the percent chance of the effect reaching the 
substantial change threshold was <25% and the effect was clear, it was classified as a 
‘trivial’ effect. If 90% confidence intervals included values that exceeded the substantial 
change threshold for both a positive and negative effect, effects were classified as 
unclear (>5% chance of reaching the substantial threshold for both a positive and 
negative effect). For ease of interpretation data are displayed as raw means ± SD. 
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Table 2.1 Subject Characteristics 
 Age (yrs) Height (cm) Weight (kg) 
Recent Physical Activity  
(Days/Week) 
 
Weekly Caffeine Usage  
(Servings of Coffee + Soda) 
 
Male (n = 17) 21.1  1.7 169  30 81.2  21.3 4.9  1.5 
 
3.8  5.3 
Female (n = 8) 21.1  1.8 163  9 57.9  7.2 5.3  1.1 6.8  9.3 
Total (n = 25) 21.1  1.7 167  25 73.8  21.0 5.0  1.4 4.8  6.8 
Data are displayed as means  SD 
 15 
Chapter 3 
Results 
 Average performance times and power output for all treatment conditions and 
qualitative inferences about treatment comparisons are displayed in Tables 3.1 and 3.2.  
CAF-CAF and CAF-PLA treatments both ‘likely’ improved performance time by 1.4% 
and 1.7% compared to PLA-PLA. It was unclear whether the PLA-CAF treatment had 
any effect on 3-km time trial performance compared to PLA-PLA. When compared to 
the PLA-CAF treatment, CAF-PLA had a ‘very likely’ beneficial effect on performance 
time (96.9% likelihood), improving finishing time by 1.9%.  When looking at the 
statistical outcomes for each split time, PLA-CAF ‘likely’ improved performance time in 
both the second and third split when compared to PLA-PLA. Similarly, CAF-CAF 
treatment also ‘likely’ improved performance time for the 3-km split compared to PLA-
PLA.   
 Mean 3-km power outputs are shown in Table 3.2. Mean power output for CAF-
CAF and CAF-PLA were improved by 4.6% and 4.5%, respectively, when compared to 
the PLA-PLA treatment. There was no significant difference in average power outputs in 
PLA-CAF treatment when compared to PLA-PLA.  
Individual data for the 3-km times are also displayed in Figures 3.1 and 3.2. Note 
that data points below the line of identity reflect an improvement in 3-km time in the 
CAF-PLA or PLA-CAF trials. 18 out of 25 individuals performed better after caffeine 
ingestion (CAF-PLA vs. PLA-PLA), whereas only 12 out of 25 performed faster with the 
caffeine mouth-rinse (PLA-CAF vs. PLA-PLA). 
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Table 3.1. 3-km Time Trial Performance – Qualitative Inferences  
Comparison 
Time Difference (sec)  
 90% CL 
Clinical Inference 
PLA-PLA vs. PLA-CAF -0.82  3.4 Unclear 
PLA-PLA vs. CAF-CAF 4.3  3.3 
CAF-CAF Likely Beneficial 
(84.8% likelihood) 
PLA-PLA vs. CAF-PLA 5.1  3.3 
CAF-PLA Likely Beneficial 
(92.4% likelihood) 
PLA-CAF vs. CAF-CAF 5.2  4.6 
CAF-CAF Likely Beneficial 
(84.8% likelihood) 
PLA-CAF vs. CAF-PLA 6.0  3.2 
CAF-PLA Very Likely Beneficial 
(96.9% likelihood) 
CAF-CAF vs. CAF-PLA -0.80  3.4 Unclear 
Data are displayed as means  SD 
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Table 3.2 3-km Time Trial Finishing Time and Split Times for 1-km, 2-km, and 3-km During 3-km-Time Trial  
 Total 3 Kilometer Kilometer 1 Kilometer 2 Kilometer 3 
PLA-PLA 
309.5  29.5  
(239  55 W) 
101.2  11.5  
(261  67 W) 
105.3  9.7 
 (223  50 W) 
103.1  9.7 
 (238  59 W) 
PLA-CAF 
 
310.3  28.2  
(237  53 W) 
102.8  11.9  
(248  68 W) 
104.9  9.2  
(225  50 W) 
102.6  9.4 
 (241  59 W) 
CAF-CAF 
305.2  24.7a  
(250  45 W) 
98.5  8.2c 
 (273  59 W) 
103.0  7.4e 
 (233  43 W) 
101.2  8.2g 
 (249  53 W) 
CAF-PLA 
304.4  28.3b  
(250  58 W) 
99.7  9.8d 
 (267  63 W) 
103.2  9.6f  
(236  55 W) 
101.5  10.0h 
 (248  63 W) 
 
aCAF-CAF vs. PLA-PLA Likely (84.8%); bCAF-PLA vs. PLA-PLA Likely (92.4%); cCAF-CAF vs. PLA-PLA Possible 
(47.6%); dCAF-PLA vs. PLA-PLA Possible (43.2%);  eCAF-CAF vs. PLA-PLA Possible (73.3%); fCAF-PLA vs. PLA-PLA 
Likely (93.3%); gCAF-CAF vs. PLA-PLA Likely (81.3%); hCAF-PLA vs. PLA-PLA Very Likely (96.4%). All other treatment 
comparisons were unclear.  
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Figure 3.1. 3-km Finishing Times – Individual Responses – Caffeine Mouth Rinse (PLA-CAF) Compared to 
Placebo Conditions (PLA-PLA). The line of identity reflects no difference between the two trials. Data points below the 
line of identity reflect an improved 3-km time in the PLA-CAF condition. 
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Figure 3.2. 3-km Finishing Times – Individual Responses – Caffeine Capsule (CAF-PLA) Compared to Placebo 
Conditions (PLA-PLA). The line of identity is plotted and reflects no difference between the two trials. Data points below 
the line of identity reflect an improved 3-km time in the CAF-PLA condition.  
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Chapter 4 
Discussion 
 We assessed 3-km time trial performance in response to a combination of 
caffeine ingestion and caffeine mouth-rinse treatments. As hypothesized, caffeine 
capsule intake ‘very likely’ improved 3-km TT performance, evidenced by 1.4% and 
1.7% improvements in both caffeine capsule trials. This finding is consistent with a large 
body of literature. The most novel aspect of this investigation was the inclusion of the 
mouth-rinse conditions. Our results indicate that the performance effect of caffeine 
mouth rinsing is unclear. Likewise, the addition of the caffeine mouth in the trials where 
subjects had already consumed a caffeine capsule failed to elicit a clear effect.  
 Very few studies have evaluated the impact of a caffeine mouth-rinse prior to 
exercise, with only one study observing potential benefits from this strategy (Beaven et 
al., 2012). Beaven (2012) reported that a caffeine mouth-rinse solution administered 
immediately prior to exercise rapidly enhanced maximal voluntary power production. 
Differences in experimental conditions and subject characteristics may be responsible 
for the contrasting results. It may be that caffeine mouth rinse increases excitatory drive 
for a brief period of time that does not translate to longer sustained performances. This 
is reinforced by a recent report that caffeine mouth rinsing does not impart performance 
benefits in a performance protocol lasting around 1 hour (Doering, 2013). Similar to our 
findings, Doering observed no significant improvement in cycling time trial performance 
from a caffeine mouth-rinse (3918243s) compared to placebo (3940227s) (Doering, 
2013). When combined with the previous related literature, caffeine mouth rinse may 
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facilitate a brief improvement in power output that does not translate to events lasting 
longer than ~3 minutes.  
 An additional possibility for the lack of a performance effect with caffeine mouth 
rinsing is the confounding effect of previous caffeine habits. A number of studies have 
investigated the benefits of caffeine ingestion prior to exercise in habitual caffeine users 
versus non-users. Early work indicated that habitually high caffeine users acquire a 
tolerance to caffeine, reducing its effects during prolonged exercise (Fisher, 1986). Bell 
et al. (2002) observed similar effects, as both duration and magnitude of the ergogenic 
effect following caffeine ingestion was greater in caffeine nonusers compared to users.  
Other studies have confirmed these findings (Tarnolpolsky et al., 1989 and Van Soeren 
et al., 1993). In concert with this phenomenon, Beaven noted that subjects self-reported 
as light caffeine users (Beaven, 2012) in the aforementioned study that observed and 
increase in peak power following a caffeine mouth rinse. Moreover, a subset of non-
users responded favorably to the caffeine mouth rinse administered by Doering, 
whereas users were not influenced by the caffeine rinse. While not systematically 
addressed, it is possible that we happened to recruit a large number of heavy users of 
caffeine, thereby blunting any potential response to the mouth-rinse. However, this is 
somewhat unlikely because we did find an overall improvement in the caffeine capsule 
times versus the placebo (18/25 subjects performed better with caffeine ingestion alone, 
indicating our study had an adequate number of ‘responders’ to caffeine).   
 Another explanation for the absence of a benefit with the caffeine rinse may be 
related to the bitter taste of caffeine.  While providing a bitter tasting placebo mouth-
rinse is one of the strengths of this investigation because of its indistinguishable taste 
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from the caffeine mouth-rinse, recent data suggests that bitterness may also improve 
performance. Gam (2014) found that when individuals rinsed a bitter tasting quinine 
solution prior to a 30 second cycling sprint, mean power output was improved by 2.4-
3.9% when compared to water, a sweet aspartame solution, or no solution at all. 
Therefore, it is possible that the bitter taste of the placebo rinse actually enhanced 
performance, thereby minimizing or masking any potential effect that the caffeine may 
have elicited on its own.  
 While the effectiveness of a caffeine mouth-rinse remains unclear, it is evident 
that a caffeine capsule ‘likely’ improved 3-km time trial performance. While few studies 
found no improvements in performance with caffeine ingestion prior to exercise (Bell, 
1998, Doherty, 2002, and Beck, 2008), the findings in this study were consistent with 
the larger body of the literature (Costill, 1977; Pasman, 1995, Cole, 1996; Greer, 2000; 
Jenkins, 2008; and McNaughton, 2008). However, only 18 of the 25 subjects 
participating in this study performed better after caffeine capsule ingestion, meaning 
that about 30 percent of individuals saw no benefit from taking a caffeine capsule prior 
to their 3-km time trial. This is consistent with the number of non-responders reported in 
prior work by Doherty (1998). Recent work suggests that a (C/A) single-nucleotide 
polymorphism (variant allele at a single position) on the CYP1A2 gene (which encodes 
for cytochrome p450, a key hepatic enzyme involved in caffeine metabolism) may 
partially mediate the individual ergogenic response to caffeine consumption (Womack et 
al., 2012). Specifically, caffeine significantly improved 40-km cycling time trial 
performance in AA homozygotes (3.8 minutes) to a greater extent than C allele carriers 
(1.3 minutes) (Womack, et al., 2012). This polymorphism and genetic variation is a 
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possible reason as to why close to one-third of subjects in this study saw no benefit 
from caffeine ingestion. Interestingly, of the 7 individuals that were non-responders to 
the caffeine capsule, 5 also saw no effect from the caffeine mouth-rinse.  
 While this study presents several small limitations to the generalizability of our 
findings, the double-blind, counterbalanced, and randomized design of our study 
provides a strong basis for our conclusion that a caffeine mouth-rinse is of limited 
ergogenic value. The present study demonstrates that a 1.2% weight/volume caffeine 
mouth-rinse does not improve, nor impair TT cycling performance. However, caffeine 
ingestion improved performance time in most individuals, and is a ‘likely’ beneficial 
treatment prior to a 3-km time trial. Collectively, this data suggests that a majority of 
individuals will benefit from caffeine ingestion prior to high intensity cycling, while very 
few will benefit with a caffeine mouth-rinse alone. Further work should be done to better 
profile the influence habitual caffeine usage has on the effects of a caffeine mouth-rinse, 
as well as examine the genetic influence (if any) on the response to a caffeine mouth-
rinse.  
 
 
 
 
 
 
 
 
 24 
References 
Anselme F., Collomp K., Mercier B., Ahmaidi S., Prefaut C. 1992. Caffeine increases 
maximal anaerobic power and blood lactate concentration. European Journal of Applied 
Physiology and Occupational Physiology. 65(2): 188-191. 
 
Beaven, C. M., Maulder, P., Pooley, A., Kilduff, L., & Cook, C. 2013. Effects of caffeine 
and carbohydrate mouth rinses on repeated sprint performance. Applied Physiology, 
Nutrition, and Metabolism. 38(999): 633-637. 
 
Bell D.G., Jacobs I., Ellerington K. 2001. Effect of caffeine and ephedrine ingestion on 
anaerobic exercise performance. Medicine and Science in Sports and Exercise. 33(8): 
1399-1403. 
 
Bell, D. G., Jacobs, I., & Zamecnik, J. 1998. Effects of caffeine, ephedrine and their 
combination on time to exhaustion during high-intensity exercise. European Journal of 
Applied Physiology and Occupational Physiology. 77(5): 427-433. 
 
Bell, D. G., & McLellan, T. M. 2002. Exercise endurance 1, 3, and 6 h after caffeine 
ingestion in caffeine users and nonusers. Journal of Applied Physiology. 93(4): 1227-
1234. 
 
Beck, T. W., Housh, T. J., Malek, M. H., Mielke, M., & Hendrix, R. 2008. The acute 
effects of a caffeine-containing supplement on bench press strength and time to running 
exhaustion. The Journal of Strength & Conditioning Research. 22(5): 1654-1658. 
 
Bytomski, J., & Parker, B. 2011. Caffeine and exercise. In L. Micheli (Ed.), Encyclopedia 
of Sports Medicine. 214-216. 
 
Carter, J. M., Jeukendrup, A. E., & Jones, D. A. 2004. The effect of carbohydrate mouth 
rinse on 1-h cycle time trial performance. Medicine and Science in Sports and Exercise. 
36(12): 2107-2111. 
 
Cole, K. J., Costill, D. L., Starling, R. D., Goodpaster, B. H., Trappe, S. W., & Fink, W. J. 
1996. Effect of caffeine ingestion on perception of effort and subsequent work 
production. International Journal of Sport Nutrition. 6: 14-23. 
 
Davis, J. M., Zhao, Z., Stock, H. S., Mehl, K. A., Buggy, J., & Hand, G. A. 2003. Central 
nervous system effects of caffeine and adenosine on fatigue. American Journal of 
Physiology-Regulatory, Integrative and Comparative Physiology. 284(2): R399-R404. 
 
Doering, T. M., Fell, J. W., Leveritt, M. D., Desbrow, B., & Shing, C. M. 2013. The Effect 
of a Caffeinated Mouth-Rinse on Endurance Cycling Time-Trial Performance. 
International Journal of Sport Nutrition and Exercise Metabolism. 
 
 25 
Doherty, M. 1998. The effects of caffeine on the maximal accumulated oxygen deficit 
and short-term running performance. International Journal of Sport Nutrition. 8: 95-104. 
 
Doherty, M. I. K. E., Smith, P. M., Davison, R. R., & Hughes, M. G. 2002. Caffeine is 
ergogenic after supplementation of oral creatine monohydrate. Medicine and Science in 
Sports and Exercise. 34(11): 1785-1792. 
 
Erickson, M. A., Schwarzkopf, R. J., & McKenzie, R. D. 1987. Effects of caffeine, 
fructose, and glucose ingestion on muscle glycogen utilization during exercise. Medicine 
and Science in Sports and Exercise. 19(6): 579. 
 
Fisher, S. M., McMurray, R. G., Berry, M., Mar, M. H., & Forsythe, W. A. 1986. Influence 
of caffeine on exercise performance in habitual caffeine users. International Journal of 
Sports Medicine. 7(5): 276-280. 
 
Gam, S., Guelfi, K. J., & Fournier, P. A. 2014. Mouth Rinsing and Ingesting a Bitter 
Solution Improves Sprint Cycling Performance. Medicine and Science in Sports and 
Exercise. 
 
Graham T.E. 2001. Caffeine and Exercise: Metabolism, Endurance and Performance. 
Sports Medicine. 31(11): 785-807. 
 
Graham T.E. 2001. Caffeine and Exercise: Metabolism, Endurance and Performance. 
Sports Medicine. 31(11): 785-807. 
 
Graham, T.E., and Spriet, L.L. 1991. Performance and metabolic responses to a high 
caffeine dose during prolonged exercise. Journal of Applied Physiology. 71(6): 2292–
2298.  
 
Greer, F., Friars, D., & Graham, T. E. 2000. Comparison of caffeine and theophylline 
ingestion: exercise metabolism and endurance. Journal of Applied Physiology. 89(5): 
1837-1844. 
 
McCall, A. L., Millington, W. R., & Wurtman, R. J. 1982. Blood-brain barrier transport of 
caffeine: dose-related restriction of adenine transport. Life Sciences. 31(24): 2709-2715. 
 
Jacobson, T. L., Febbraio, M. A., Arkinstall, M. J., & Hawley, J. A. 2001. Effect of 
caffeine co-ingested with carbohydrate or fat on metabolism and performance in 
endurance-trained men. Experimental physiology. 86(1): 137-144. 
 
Pasman, W.J., van Baak, M.A., Jeukendrup, A.E., de Haan, A. 1995. The effect of 
different dosages of caffeine on endurance performance time. International Journal of 
Sports Medicine. 16(4): 225-230. 
 
 26 
Paton, C. D., Lowe, T., & Irvine, A. 2010. Caffeinated chewing gum increases repeated 
sprint performance and augments increases in testosterone in competitive cyclists. 
European Journal of Applied Physiology. 110(6): 1243-1250. 
 
Rollo, I., Williams, C., Gant, N., & Nutea, M. 2008. The influence of carbohydrate mouth 
rinse on self-selected speeds during a 30-min treadmill run. International Journal of 
Sport Nutrition & Exercise Metabolism. 18(6). 
 
Van Soeren, M. H., Sathasivam, P., Spriet, L. L., & Graham, T. E. 1993. Caffeine 
metabolism and epinephrine responses during exercise in users and nonusers. Journal 
of Applied Physiology. 75(2): 805-812. 
 
Womack, C. J., Saunders, M. J., Bechtel, M. K., Bolton, D. J., Martin, M., Luden, N. D., 
... & Hancock, M. 2012. The influence of a CYP1A2 polymorphism on the ergogenic 
effects of caffeine. Journal of the International Society of Sports Nutrition. 9(1): 7. 
